Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Robert Kiss's research focuses on understanding and improving cancer treatments, particularly those involving chemotherapy. His work investigates strategies to enhance the therapeutic index of cisplatin-based treatments by targeting the DNA damage response and repair mechanisms within cancer cells. This approach aims to make these therapies more effective while potentially reducing side effects. Kiss has published on methods to overcome resistance to chemotherapy and to synergize drug treatments with agents that modulate DNA repair pathways. His scholarship metrics include an h-index of 17 and 35 total publications, with 993 citations. He has collaborated with Fen Xia at the University of Arkansas for Medical Sciences on at least one publication.
Metrics
- h-index: 17
- Publications: 35
- Citations: 997
Selected Publications
-
Pathologic Variability Associated With Phenotypic Differences in Siblings With <scp>ACTA1</scp> Myopathy (2026)
-
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment (2021)
Collaboration Network
Top Collaborators
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
Similar Researchers
Based on overlapping research topics